Product Information
DIURIL 250 MG/5 ML ORAL SUSP is a brand product labeled by Salix Pharmaceuticals Inc., priced at $0.3062 per ML under NDC 65649031112. Its NADAC has been published 463 times since Nov 28, 2013.
FDA first approved this application before 1982.
Strength
250 mg/5mL
Manufacturer
Salix Pharmaceuticals Inc.NDC
65649031112
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
CHLOROTHIAZIDEApproval Type
New Drug (NDA)
FDA Application
NDA011870FDA Approved
Before 1982
On Market Since
2/15/1962
Pharmacological Classes
Price Statistics
The NADAC for DIURIL 250 MG/5 ML ORAL SUSP has been published 463 times since Nov 28, 2013, and over the history we have for it it has risen 38.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3062 per ML |
|---|---|
| All-time high | $0.3062 (Oct 1, 2025) |
| All-time low | $0.2198 (Jun 18, 2014) |
| Median price | $0.2782 |
| Average price | $0.2634 |
| Largest weekly change | +9.9% (Sep 24, 2025) |
| Weeks tracked | 463 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+9.3%
5Y
+10.1%
All
+38.6%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CHLOROTHIAZIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Salix Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CHLOROTHIAZIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thiazide Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIURIL 250 MG/5 ML ORAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for DIURIL 250 MG/5 ML ORAL SUSP, manufactured by Salix Pharmaceuticals Inc., is $0.3062 per ML (NDC 65649031112), effective Oct 1, 2025.
How has the price of DIURIL 250 MG/5 ML ORAL SUSP changed over time?
Over the history we have for it, the NADAC for DIURIL 250 MG/5 ML ORAL SUSP has risen 38.6%. It has been tracked across 463 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIURIL 250 MG/5 ML ORAL SUSP?
Since Nov 28, 2013, the NADAC for DIURIL 250 MG/5 ML ORAL SUSP has ranged from a low of $0.2198 (Jun 18, 2014) to a high of $0.3062 (Oct 1, 2025), with a median of $0.2782 per ML.
Are there cheaper alternatives to DIURIL 250 MG/5 ML ORAL SUSP?
No other NADAC-published product currently shares the active ingredient and strength of DIURIL 250 MG/5 ML ORAL SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIURIL 250 MG/5 ML ORAL SUSP?
DIURIL 250 MG/5 ML ORAL SUSP (NDC 65649031112) is labeled by Salix Pharmaceuticals Inc., and CMS classifies it as a brand product.